SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
LILRB1 |
IPI00385703 |
0.295 |
Evidence |
|
CGB |
CGB, CGB3, CGB5, CGB7, CGB8: Choriogonadotropin subunit beta precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
0.295 |
Evidence |
|
CD44 |
IPI00305064 |
CFP |
CFP, PFC: Properdin precursor |
0.295 |
Evidence |
|
THY1 |
THY1: Thy-1 membrane glycoprotein precursor |
MAPK8IP1 |
MAPK8IP1, IB1, JIP1, PRKM8IP: C-jun-amino-terminal kinase-interacting protein 1 |
0.295 |
Evidence |
|
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.295 |
Evidence |
|
ARFGAP1 |
IPI00175169 |
EHD1 |
EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 |
0.295 |
Evidence |
|
PLEK |
PLEK, P47: Pleckstrin |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.295 |
Evidence |
|
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
DOK1 |
DOK1: Docking protein 1 |
0.295 |
Evidence |
|
PLXNB1 |
PLXNB1, KIAA0407, PLXN5, SEP: Plexin-B1 precursor |
TLN2 |
TLN2: Uncharacterized protein TLN2 |
0.295 |
Evidence |
|
NCAM1 |
NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor |
FGF9 |
FGF9: Glia-activating factor precursor |
0.295 |
Evidence |
|
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
0.295 |
Evidence |
|
CXorf9 |
IPI00004504 |
SORL1 |
SORL1: Sortilin-related receptor precursor |
0.295 |
Evidence |
|
IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
DOK1 |
DOK1: Docking protein 1 |
0.295 |
Evidence |
|
HNRPA0 |
HNRPA0: Heterogeneous nuclear ribonucleoprotein A0 |
PCBP2 |
PCBP2: Poly(rC)-binding protein 2 |
0.295 |
Evidence |
|
CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
MSN |
MSN: Moesin |
0.295 |
Evidence |
|
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
0.295 |
Evidence |
|
ANXA2 |
ANXA2, ANX2, ANX2L4, CAL1H, LPC2D: Annexin A2 |
ACTN1 |
ACTN1: Alpha-actinin-1 |
0.295 |
Evidence |
|
STIP1 |
STIP1: Stress-induced-phosphoprotein 1 |
PSMD4 |
PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 |
0.295 |
Evidence |
|
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
0.295 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.295 |
Evidence |
|
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.295 |
Evidence |
|
ADAM23 |
ADAM23, MDC3: ADAM 23 precursor |
TLN2 |
TLN2: Uncharacterized protein TLN2 |
0.295 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.295 |
Evidence |
|
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
CD2AP |
CD2AP: CD2-associated protein |
0.295 |
Evidence |
|
PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
0.295 |
Evidence |
|